Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Satellos Bioscience Inc
T.MSCL
Alternate Symbol(s):
MSCLF
Healthcare
Biotechnology
Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and...
regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MSCL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
Next
(410)
•••
beenthere
X
View Profile
View Bullboard History
Post by
beenthere
on Mar 12, 2024 4:51pm
Sure Glad The Boys Moved To The TSX
Hate to think where we would be without that move!
(410)
•••
beenthere
X
View Profile
View Bullboard History
Comment by
beenthere
on Jan 25, 2024 5:46pm
RE:Great day for Satellos
Yes for sure! It's definitely your lucky day! lol Can I ask if you researched this company at all? Did you check the background of where this company came from? Did you check to see
...more
Q Precious & Battery Metals to Drill Initial 1000 metres at La Corne and McKenzie East Gold Projects, Quebec
posted Apr 18, 2024 9:00am by
Q Precious & Battery Metals Corp
-
|
The Company is planning for an initial 1,000 metres of diamond drilling scheduled for mid- June 2024, with VMS targets on the La Corne South project at proposed depths ranging from 50 to 300 metres below surface as modelled by the EM survey and noted in historic drilling. TMC Geophysique completed deep-penetrating Pulse-EM -Time Domain Electromagnetic (TDEM) surveying on the claims that targeted ...read more
(2)
•••
JohnnyChanginit
X
View Profile
View Bullboard History
Post by
JohnnyChanginit
on Jan 16, 2024 11:05am
Great day for Satellos
The TSX lising and prestigious award/recognition in one day! Soo glad I own this and just adding!
(116)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on Jan 16, 2024 10:02am
BUSINESS WIRE
Satellos Receives Conditional Approval to Graduate to the Toronto Stock Exchange G1945V
(18)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Nov 21, 2023 4:51pm
15,000 gets you……..
Up 23% back to the price which the stock was trading at when they hired ICP Securities Inc. Christmas bonuses all around lol
(18)
•••
Drambuey
X
View Profile
View Bullboard History
Post by
Drambuey
on Nov 01, 2023 4:55pm
What does $7,500 a month get you
Stock price down 23% since signing ICP Securities marketing services.
(1902)
•••
nozzpack
X
View Profile
View Bullboard History
Post by
nozzpack
on Aug 02, 2023 7:52am
Substantive News....Receives Orphan Drug Status !
ORIGINAL: Satellos Bioscience Receives Orphan Drug Designation from the U.S. FDA for SAT-3153, a First-in-Class Small Molecule Therapeutic for Duchenne Muscular Dystrophy Company also
...more
(7)
•••
london6ers
X
View Profile
View Bullboard History
Comment by
london6ers
on Aug 01, 2023 4:29pm
RE:RE:RE:Ranked #1
Yes plus many other applications.
(7)
•••
london6ers
X
View Profile
View Bullboard History
Post by
london6ers
on Jul 25, 2023 1:13pm
🤔
How can you replace fatty tissue with healthy muscle cells?
(7)
•••
london6ers
X
View Profile
View Bullboard History
Comment by
london6ers
on Jul 25, 2023 12:53pm
RE:RE:RE:Ranked #1
I agree but lots of the muscle is filled by scar tissue. What does this do? Replace scar tissue with functioning muscle cells? That's crazy if true..
(1902)
•••
nozzpack
X
View Profile
View Bullboard History
Comment by
nozzpack
on May 23, 2023 1:41pm
RE:RE:Ranked #1
This will be a 25 bagger if that small molecule drug with the potential to regenerate functional muscle is successful as it will have many advantages and benefits for patients muscular
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 17, 2023 5:29pm
New Press Release - Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Toronto, Ontario--(Newsfile Corp. - May 17, 2023) - Bloom Burton & Co. Inc. announces that, today, it and its affiliate acquired 1,453,070 common shares (Shares) and 6,636,734 compensation options (Compensation Options) of Satellos Bioscience Inc. (Corporation) in connection with a public...
read article.
(116)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on May 17, 2023 9:43am
Satellos closes $55M Financing
Satellos Bioscience Closes $55M Financing to Support Development of its Lead Drug Candidate for Duchenne Muscular Dystrophy G1945V
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 19, 2023 10:46am
New Press Release - IIROC Trading Resumption - MSCL
VANCOUVER, BC, April 19, 2023 /CNW/ - Trading resumes in:Company: Satellos Bioscience Inc.TSX-Venture Symbol: MSCLAll Issues: YesResumption (ET): 11:00 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 19, 2023 10:26am
New Press Release - Satellos Bioscience Inc. Announces Pricing of Public Offering
Toronto, Ontario--(Newsfile Corp. - April 19, 2023) - Satellos Bioscience Inc. (TSXV: MSCL) ("Satellos" or the "Company"), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, is pleased to announce the pricing and terms of...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Q Precious & Battery Metals Contracts First Class Drilling for Quebec Projects
Why the Tonopah Gold Project is One to Watch
Targeting Nevada and Ontario for the Critical Minerals Supply Chain
Asset Sale Allows Biotech Company to Refocus on the High Value Dermatological Market
Positive PEA for Uranium-Vanadium Deposit After-tax NPV 8%: $227.7 million with IRR: 38.9%
Fokus Mining Welcomes Luc Gervais To Its Board Of Directors